01-03-2014 | Stem Cell Transplantation (R Maziarz, Section Editor)
Treatment of Older Patients with High-Risk Myelodysplastic Syndromes (MDS): The Emerging Role of Allogeneic Hematopoietic Stem Cell Transplantation (Allo HSCT)
Published in: Current Hematologic Malignancy Reports | Issue 1/2014
Login to get access